Chanell earned a B.S. in Bioengineering from North Carolina A & T University. She is a Ph.D student in Charlie Gersbach's lab studying Orthogonal Screening Approaches to Identify Novel Therapeutic Vulnerabilities in NF1 Neurofibromas and MPNSTs.